Fintel reports that on September 27, 2024, Leerink Partners downgraded their outlook for Agios Pharmaceuticals (NasdaqGS:AGIO ...

Agios Pharmaceuticals (AGIO) stock was downgraded at Leerink Partners on Pfizer's (PFE) recent decision to withdraw sickle ...

On Friday, Geron Corp (GERN) stock saw a modest uptick, ending the day at $4.57 which represents a slight increase of $0.14 or 3.16% from the prior close of $4.43. The stock opened at $4.47 and ...

Leerink Partners analyst Faisal Khurshid said that he likes the “risk/reward” profile of Immunic’s CALLIPER trial readout, ...

On Friday, Ardelyx Inc (ARDX) stock saw a modest uptick, ending the day at $6.65 which represents a slight increase of $0.29 or 4.56% from the prior close of $6.36. The stock opened at $6.43 and ...

Leerink Partners analyst Puneet Souda reiterated a Buy rating on Quanterix (QTRX – Research Report) today. The company’s shares ...

Pfizer’s sudden market withdrawal of sickle cell therapy Oxbryta, which some analysts predicted would reach $750 million in ...

Leerink Partners analyst Mani Foroohar has maintained their bullish stance on ENGN stock, giving a Buy rating on September 27. Mani Foroohar ...

ICON Public Limited (ICLR) stock gained as Leerink launched its coverage with a bullish view, citing its business focused on ...

Novo Nordisk’s American depositary receipts tumbled almost 6% Friday after the drugmaker reported mixed results from a study of an experimental weight-loss pill. The pill, monlunabant, helped people ...

Capstan Therapeutics to participate in Goldman Sachs Cell Therapy Day 2024 and Leerink Partners Biopharma Private Company Connect.

Guggenheim Securities, LLC served as financial advisor to eClinical Solutions. Morse, Barnes-Brown & Pendleton, and Choate Hall & Stewart LLP served as legal counsel to eClinical Solutions. Leerink ...